Current Report

    

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): July 27, 2012


 

PetMed Express, Inc.
(Exact name of registrant as specified in its charter)

 

 

 

 

 

Florida

 

000-28827

 

65-0680967

(State or other jurisdiction
of incorporation)

 

(Commission
File Number)

 

(I.R.S. Employer
Identification No.)



1441 S.W. 29th Avenue,  Pompano Beach, FL  33069

(Address of principal executive offices) (Zip Code)



(954) 979-5995

 

(Registrant’s telephone number, including area code)

 



Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):


¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 





Item 5.07   Submission of Matters to a Vote of Security Holders.


PetMed Express, Inc. (the “Company”, “we”, or “our”) held its Annual Meeting of Stockholders in Ft. Lauderdale, Florida on July 27, 2012.  Stockholders voted on the following proposals:


1.

To elect five Directors to the Board of Directors for a one-year term expiring in 2013;


2.

To conduct an advisory (non-binding) vote on executive compensation;


3.

To ratify the appointment of McGladrey LLP, as the independent registered public accounting firm for the Company to serve for the 2013 fiscal year;


4.

To ratify the amendment to the Company’s 2006 Outside Director Equity Compensation Restricted Stock Plan to increase from 200,000 to 400,000 the number of shares available for issuance under the plan, and to provide for an automatic increase every year in the amount of shares available for issuance to this plan as well as to the Company’s 2006 Employee Equity Compensation Restricted Stock Plan of 10% of the shares authorized under each plan.


With a majority of the outstanding shares voting either by proxy or in person, our stockholders approved all four proposals, with voting as follows:


Proposal 1:

 

For

 

Abstain/Withhold

 

Broker Non-Vote

Election of Directors:

 

 

 

 

 

 

Menderes Akdag

 

13,113,357

 

229,737

 

5,063,702

Frank J. Formica

 

13,089,077

 

254,017

 

5,063,702

Gian M. Fulgoni

 

13,088,816

 

254,278

 

5,063,702

Ronald J. Korn

 

13,087,158

 

255,936

 

5,063,702

Robert C. Schweitzer

 

13,088,364

 

254,730

 

5,063,702


Proposal 2:

  

Approval of the compensation of the named executive officers, as disclosed in the Company’s Proxy Statement for the Annual Meeting of Stockholders (advisory non-binding vote).


Shares For

 

Shares Against

 

Abstain

 

Broker Non-Vote

13,008,964

 

307,451

 

26,677

 

5,063,702


Proposal 3:


To ratify the appointment of McGladrey LLP as the independent registered public accounting firm for the Company to serve for the 2013 fiscal year.


Shares For

 

Shares Against

 

Abstain

 

Broker Non-Vote

18,170,940

 

200,788

 

35,068

 

0


Proposal 4:


To ratify the amendment to the Company’s 2006 Outside Director Equity Compensation Restricted Stock Plan to increase from 200,000 to 400,000 the number of shares available for issuance under the plan, and to provide for an automatic increase every year in the amount of shares available for issuance to this plan as well as to the Company’s 2006 Employee Equity Compensation Restricted Stock Plan of 10% of the shares authorized under each plan.


Shares For

 

Shares Against

 

Abstain

 

Broker Non-Vote

7,802,716

 

5,449,470

 

90,907

 

5,063,702


2






SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: July 30, 2012


 

PETMED EXPRESS, INC.

 

 

 

 

By:

/s/ Bruce S. Rosenbloom

 

Name:

Bruce S. Rosenbloom

 

Title:

Chief Financial Officer

 

 

 

3